| Name | 2-pyridin-4-yl-1,3-thiazol-4-amine |
|---|---|
| Synonyms |
2-(pyridin-4-yl)thiazol-4-amine
2-(4-pyridyl)-1,3-thiazole-4-ylamine 2-(pyrid-4-yl)-4-amino-thiazole 2-pyridin-4-yl-4-thiazolamine 4-Thiazolamine,2-(4-pyridinyl) 4-amino-2-(4'-pyridinyl)-thiazole 2-(pyridin-4-yl)-1,3-thiazole-4-ylamine 2-(PYRIDIN-4-YL)-THIAZOL-4-YLAMINE |
| Molecular Formula | C8H7N3S |
|---|---|
| Molecular Weight | 177.22600 |
| Exact Mass | 177.03600 |
| PSA | 80.04000 |
| LogP | 2.36850 |
| HS Code | 2934100090 |
|---|
|
~%
89401-67-2 |
| Literature: Huang, Qi; Kaller, Matthew; Nguyen, Thomas; Norman, Mark H.; Rzasa, Robert; Wang, Hui-Ling; Zhong, Wenge Patent: US2003/229068 A1, 2003 ; Location in patent: Page 57 ; US 20030229068 A1 |
|
~%
89401-67-2 |
| Literature: VERTEX PHARMACEUTICALS INCORPORATED Patent: WO2004/41813 A1, 2004 ; Location in patent: Page 111-112 ; WO 2004/041813 A1 |
| Precursor 2 | |
|---|---|
| DownStream 0 | |
| HS Code | 2934100090 |
|---|---|
| Summary | 2934100090 other compounds containing an unfused thiazole ring (whether or not hydrogenated) in the structure VAT:17.0% Tax rebate rate:9.0% Supervision conditions:none MFN tariff:6.5% General tariff:20.0% |